
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : COVID-19 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Indian Institute of Science
Deal Size : Inapplicable
Deal Type : Inapplicable
India's 'Warm' Vaccine Candidate Effective Against Delta, Omicron Variants in Mice: Study
Details : A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
April 16, 2022
Lead Product(s) : COVID-19 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Indian Institute of Science
Deal Size : Inapplicable
Deal Type : Inapplicable
